Health and Healthcare
Indonesia Stops Sharing Bird Flu Samples Pending Baxter Collaboration
Published:
by H.S. Ayoub
BioHealth Investor.com
According to the Financial Times, last month the Indonesian government stopped sharing key samples of H5N1 avian flu virus with international laboratories and researchers pending a planned collaboration with pharmaceutical giant Baxter (BAX).
It is expected that government officials and Baxter representatives will announce plans for the development of a vaccine against the deadly disease, where Baxter will have exclusive access to the viral samples. The announcement is expected some time this week.
Baxter officials quickly announced that the company will fully comply with the World Health Organization’s (WHO) rules for sharing viral samples with world institutions.
It would be interesting to find out just how big of a financial contribution Baxter will make in order for a nation such as Indonesia to suddenly worry about protecting its intellectual property rights related to the H5N1 viral strain.
http://www.biohealthinvestor.com/
Smart Investors Are Quietly Loading Up on These “Dividend Legends” (Sponsored)
If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats. There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside. If you’re tired of feeling one step behind in this market, this free report is a must-read for you.
Click here to download your FREE copy of “2 Dividend Legends to Hold Forever” and start improving your portfolio today.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
